ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 1 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $15,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | +53.8% | 4,000 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | +8.3% | 4,000 | 0.0% | 0.00% | – |
| Q3 2018 | $12,000 | +20.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | -23.1% | 4,000 | -20.0% | 0.00% | – |
| Q1 2018 | $13,000 | -13.3% | 5,000 | 0.0% | 0.00% | – |
| Q4 2017 | $15,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2017 | $15,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2017 | $15,000 | +25.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | -14.3% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $14,000 | +27.3% | 5,000 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | +37.5% | 5,000 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | -33.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | -45.5% | 5,000 | -16.7% | 0.00% | – |
| Q4 2015 | $22,000 | +22.2% | 6,000 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | +5.9% | 6,000 | +20.0% | 0.00% | – |
| Q2 2015 | $17,000 | -10.5% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $19,000 | -13.6% | 5,000 | -16.7% | 0.00% | – |
| Q4 2014 | $22,000 | +120.0% | 6,000 | +50.0% | 0.00% | – |
| Q3 2014 | $10,000 | +11.1% | 4,000 | 0.0% | 0.00% | – |
| Q2 2014 | $9,000 | -90.1% | 4,000 | -88.2% | 0.00% | – |
| Q1 2014 | $91,000 | – | 34,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|